Forte Biosciences (FBRX) Change in Acquisitions & Divestments (2016 - 2025)

Forte Biosciences (FBRX) reported Change in Acquisitions & Divestments of $36.4 million for Q1 2025, up 3634900.0% quarter-over-quarter from $1000.0 in Q4 2023.

Forte Biosciences (FBRX) Change in Acquisitions & Divestments (2016 - 2025) Analysis & Trends

Forte Biosciences (FBRX) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $36.4 million in Q1 2025.

  • Change in Acquisitions & Divestments for Q1 2025 came in at $36.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $36.4 million (up 185.7% YoY), and the FY2025 annual result was $36.4 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments climbed to $36.4 million in Q1 2025 per FBRX's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $36.4 million in Q1 2025 and troughed at $1000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Forte Biosciences 70.77 Mn 12.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 36.35 Mn
Mar 31, 2025 36.35 Mn
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Mar 31, 2020 12.72 Mn
Mar 31, 2020 12.72 Mn
Dec 31, 2019 16.84 Mn
Dec 31, 2019 16.84 Mn
Sep 30, 2019 27.69 Mn
Sep 30, 2019 27.69 Mn
Jun 30, 2019 21.11 Mn
Jun 30, 2019 21.11 Mn
Mar 31, 2019 27.84 Mn
Mar 31, 2019 27.84 Mn
Dec 31, 2018 19.34 Mn
Dec 31, 2018 19.34 Mn
Sep 30, 2018 22.73 Mn
Sep 30, 2018 22.73 Mn
Jun 30, 2018 17.37 Mn
Jun 30, 2018 17.37 Mn